- Study type: Randomised Clinical Trial, Prevention
- Study type descriptors: Randomised controlled trial, Multicentre
- Objective: To examine the safety and reactogenicity of the CD40.RBDv vaccine
- Number of participants enrolled: Enrollment data not available
- Study enrolling from to
- Study includes follow-up for 3 months
- Standardisation: MedDRA
Study Data
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Pharmacological intervention
- Vaccination
External Links
Other information
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to